Chang H L, Lefrancois L, Zaroukian M H, Esselman W J
Department of Microbiology, Michigan State University, East Lansing 48824-1101.
J Immunol. 1991 Sep 1;147(5):1687-93.
The CD45 glycoprotein family exhibits cell line-age-associated structural heterogeneity arising in part from alternate 5' exon shuffling. Previous studies of exons involved in the final glycoprotein structure have provided evidence of alternate exon use for only three exons (Ex-4, 5 and 6). However, our prior data using reverse transcription-polymerase chain reaction (RT-PCR) suggested the presence of at least one additional CD45 alternate exon. By using RT-PCR, Southern blotting with exon-specific or exon splice junction-specific oligonucleotide probes and direct DNA sequencing of RT-PCR products, we demonstrated additional alternate use involving Ex-7. PCR analysis of stage I thymocytes (CD4-CD8-) revealed only faintly detectable bands for two isoforms: one lacking Ex-4, 5, 6 and 7 (a "minus-one" [Ex(-1)] isoform), and a smaller isoform preliminarily characterized as also lacking Ex-8. Stage II thymocytes (CD4+CD8+) prominently expressed both Ex(-1) and zero alternate exon (Ex(0] isoforms, with one exon (Ex(1] and two exon (Ex(2] isoforms also present. Among stage III thymocytes, both CD4+CD8- and CD4-CD8+ cells expressed only Ex(-1) and Ex(0) isoforms. CD45 alternate exon use in resting CD4+ and CD8+ lymph node T cells was divergent, with CD8+ cells additionally expressing an Ex(2) isoform. Among alloreactive T cell clones, band intensity for the Ex(1) isoform in CD4+ BC-3 cells was much less than for resting CD4+ T cells, while the CD8+ CTL clone 8.2.2 exhibited production of the higher alternate exon isoforms, Ex(2) and Ex(3). We conclude that at least four and possibly five alternate exons exist in the CD45 glycoprotein family, with a previously unrecognized isoform lacking Ex-4, 5, 6 and 7 prominently expressed in T cells. Shuffling of CD45 alternate exons appears to occur in an organized and predictable sequence during cellular maturation and activation.
CD45糖蛋白家族表现出与细胞系龄相关的结构异质性,部分源于5'外显子的交替重排。先前对参与最终糖蛋白结构的外显子的研究仅提供了三个外显子(Ex-4、5和6)存在交替外显子使用的证据。然而,我们之前使用逆转录-聚合酶链反应(RT-PCR)的数据表明至少存在一个额外的CD45交替外显子。通过使用RT-PCR、用外显子特异性或外显子剪接连接特异性寡核苷酸探针进行Southern印迹以及对RT-PCR产物进行直接DNA测序,我们证明了涉及Ex-7的额外交替使用。对I期胸腺细胞(CD4-CD8-)的PCR分析显示,两种异构体的条带仅微弱可检测到:一种缺乏Ex-4、5、6和7(“减一”[Ex(-1)]异构体),另一种较小的异构体初步鉴定为也缺乏Ex-8。II期胸腺细胞(CD4+CD8+)显著表达Ex(-1)和零个交替外显子(Ex(0)]异构体,同时也存在一个外显子(Ex(1]和两个外显子(Ex(2]异构体。在III期胸腺细胞中,CD4+CD8-和CD4-CD8+细胞均仅表达Ex(-1)和Ex(0)异构体。静息CD4+和CD8+淋巴结T细胞中CD45交替外显子的使用存在差异,CD8+细胞还额外表达Ex(2)异构体。在同种异体反应性T细胞克隆中,如果CD4+ BC-3细胞中Ex(1)异构体的条带强度远低于静息CD4+ T细胞,而CD8+ CTL克隆8.2.2则表现出更高交替外显子异构体Ex(2)和Ex(3)的产生。我们得出结论,CD45糖蛋白家族中至少存在四个且可能五个交替外显子,一种先前未被识别的缺乏Ex-4、5、6和7的异构体在T细胞中显著表达。CD45交替外显子的重排在细胞成熟和激活过程中似乎以有组织且可预测的顺序发生。